Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Open in API
Filings indexed 1,661 across all filing types
Latest filing 2019-04-15 Major Shareholding Noti…
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
Disc. under Reg.30 of SEBI (SAST) Reg.2011
Major Shareholding Notification Classification · 95% confidence The document is a disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, dated 4th April 2019. It details the shareholding of promoters, members of promoter group, and persons acting in concert as on 31st March 2019. The content focuses on shareholding percentages and names of shareholders, which aligns with notifications of changes in significant share ownership levels. There is no financial performance data, earnings, or management discussion. The document is not an announcement of a report but a regulatory disclosure about shareholding. This fits the category of Major Shareholding Notification (MRQ). The document length is sufficient and contains detailed shareholding data, confirming it is not a brief announcement or certification. Therefore, the classification is MRQ with high confidence.
2019-04-15 English
Please find attached Compliance Certificate under Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ....
Regulatory Filings Classification · 95% confidence The document is a compliance certificate pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the half year ended 31st March 2019. It confirms that share transfer activities are maintained by the company's registrar and share transfer agent. The document is short (1569 characters) and serves as a certification or confirmation letter rather than containing substantive financial data or a full report. Therefore, it fits the criteria for a Regulatory Filing (RNS) rather than an Interim Report or any other detailed financial report.
2019-04-15 English
Trading Window
Regulatory Filings Classification · 95% confidence The document text is extremely short (128 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, no report content, no announcements, or any textual information to classify as a specific report type. Given the lack of content, the document does not fit any specific filing category and defaults to Regulatory Filings (RNS) as a fallback category.
2019-04-03 English
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended by SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018 and in accordance with the Code of ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the closure of the trading window in compliance with SEBI regulations. It references the upcoming announcement of audited financial results for the fiscal year ended March 31, 2019, and specifies the trading restrictions for insiders during this period. The document does not contain any financial data or the actual audited results but is an announcement related to trading restrictions ahead of the financial results release. The document length is short (1973 characters), and it serves as a regulatory notification rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement related to insider trading compliance and trading window closure.
2019-04-03 English
Reappointment
Regulatory Filings Classification · 95% confidence The document text contains only placeholders for images and no textual content or substantive information. The true document length is only 170 characters, which is extremely short and contains no report or announcement details. Given the lack of content, this cannot be classified as a full report or detailed announcement. It fits best as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings with no clear classification.
2019-03-30 English
Code of Conduct under SEBI(PIT) Reg., 2015
Regulatory Filings Classification · 90% confidence The document text contains only placeholders for images and no textual content or substantive information. It is extremely short (170 characters) and does not contain any report, announcement, or financial data. Given the lack of content, it cannot be classified as any specific report or announcement type. The best fit is Regulatory Filings (RNS) as a fallback category for miscellaneous or insufficient content.
2019-03-30 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.